Adenosine and Cardioprotection in the Diseased Heart

Circulation Journal

Volumn 63, Issue 4, 1999, Pages 231-243

  Kitakaze, Masafumi ^a   Minamino, Tetsuo ^a   Node, Koichi ^a   Takashima, Seiji ^a   Funaya, Hiroharu ^a   Kuzuya, Tsunehiko ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenosine; Clinical trial; Ecto 5 nucleotidase; Heart failure; Infarct size; Proten kinase C

Indexed keywords

ADENOSINE; PROTEIN KINASE C;

ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE TRIPHOSPHATE; CARDIOVASCULAR AGENTS; HEART DISEASES; HUMANS; PROTEIN KINASE C;

EID: 0032926644     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.231     Document Type: Article

References (114)

1. Hori M, Kitakaze M: Adenosine, the heart and coronary circulation (brief review). Hypertension 1991; 18: 565-574
2. Kitakaze M, Hori M, Kamada T: The role of adenosine and its interaction with alpha-adrenoceptor activity in myocardial ischemic and reperfusion injury (brief review). Cardiorasc Res 1993; 27: 18-27
3. Lagerkranser N, Sollevi A, Irestedt L, Tidgren B, Andreen M: Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in the dogs. Acta Anaesthesiol Scand 1985; 29: 45-49
4. Parmely MJ, Zhou WW, Edward III CK, Borcherding DR, Silverstein R, Morrison DC: Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrotic factor-α production and protect mice against endotoxin challenge. J Immunol 1993; 151: 389-396
5. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136
6. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356
7. Thornton JD, Liu GS, Olsson RA, Downey JM: Intravenous pretreatment with A1-selective adenosine analogue protects the heart against infarction. Circulation 1992; 85: 659-665
8. Lasley RD, Mentzer RM: Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism. Am J Physiol 1992; 263: H1460-H1465
9. Olafsson B, Forman MB, Puett DW, Pou A, Gates CU, Friesinger GC, Virmani R: Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987; 76: 1135-1145
10. Packer M: Neurohumoral interactions and adaptation in congestive heart failure. Circulation 1988; 77: 721-730
11. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin E: Effects of chronic β-adrenergic receptor blockade in consestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036
12. The SOLVD Investigations: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691
13. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-566
14. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T: Ischemic preconditioning increases adenosine release and 5′- nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implication for myocardial salvage. Circulation 1993; 87: 208-215
15. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, et al: The infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 1994; 89: 1237-1246
16. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, et al: The role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996; 93: 781-791
17. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, et al: Alpha1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994; 93: 2197-2205
18. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M: Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997; 95: 1363-1365
19. Kitakaze M, Funaya H, Minamino T, Node K, Koretsune Y, Komamura K, et al: A new strategy for the treatment of chronic heart failure: elevation of plasma adenosine levels. Cardiovasc Drugs Ther (in press)
20. Londos C, Wolff J: Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 1977; 74: 5482-5486
21. Londos C, Cooper DMF, Schlegel W, Rodbell M: Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci USA 1978; 75: 5362-5366
22. Olsson RA, Pearson JD: Cardiovascular purinoceptors. Physiol Rev 1990; 70: 761-845
23. 3H]NECA in rat striatal membranes. Mol Pharmacol 1986; 29: 331-346
24. Herlihy JT, Bockman EL, Berne RM, Rubio R: Adenosine relaxation of isolated vascular smooth muscle. Am J Physiol 1976; 230: 1239-1243
25. Harder DR, Belardinelli L, Sperelakis N, Rubio R, Berne RM: Differential effects of adenosine and nitroglycerin on the action potential of large and small coronary arteries. Circ Res 1979; 44: 176-182
26. Fenton RA, Rubio BR, Berne AM: Effect of adenosine on calcium uptake by intact and cultured vascular smooth muscle. Am J Physiol 1982; 242: H797-H804
27. Aversano T, Ouyang P, Silverman H: Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine circulation. Circ Res 1991; 69: 618-622
28. + channels. Circ Res 1997; 80: 1-10
29. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Gunther K, Goedel-Meinen L: Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247: 1341-1344
30. Nees S, Herzog V, Becker BF, Bock M, Rosiers CD, Gerlach E: The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 1985; 80: 515-529
31. Matsuda H, Imai S: Effects of adenosine and adenine nucleotides on the diameter of the isolated perfused pig coronary artery (abstract). Jpn J Pharmacol 1990; 52 (Suppl II): 116
32. Kurtz A: Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol Chem 1987; 262: 6296-6300
33. Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-H1149
34. Berne RM: Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood How. Am J Physiol 1963; 204: 317-322
35. Bardenheuer H, Schrader J: Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol 1986; 250: H173-H180
36. Schrader J, Haddy FJ, Gerlach E: Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulalion and reactive hyperemia. Pflugers Arch 1977; 369: 1-6
37. Achterberg PW, de Tombep P, Harmsen E, de Jong JW: Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochim Biophys Acta 1985; 840: 393-400
38. Sparks Jr HV, Bardenheuer H: Regulation of adenosine formation in the heart. Circ Res 1986; 58: 193-201
39. Llyod GE, Scharader J: The importance of the transmethylation pathway for adenosine metabolism in the heart. In: Gerlach E and Becker BF, editors. Topics and Perspectives in adenosine research. Berlin Heidelberg: Springer-Verlag, 1987: 199-207
40. Deussen A, Borst M, Schrader J: Formation adenosylhomocysteine in the heart. I. An index of intracellular adenosine. Circ Res 1988; 63: 240-249
41. Rubio R, Wiedmeier VT, Berne RM: Relationship between coronary flow and adenosine production and release. J Mol Cell Cardiol 1974; 6: 561-566
42. Wadsworth RM: The effects of aminophylline on the increased myocardial blood flow produced by systemic hypoxia or by coronary artery occlusion. Eur Pharmacol 1972; 20: 130-132
43. Wei HM, Kang YH, Merill GF: Canine coronary vasodepressor responses to hypoxia are abolished by 8-phenyltheophylline. Am J Physiol 1989; 257: H1043-H1048
44. Curnish RR, Berne RM, Rubio R: Effects of aminophylline on myocardial reactive hyperemia. Proc Soc Exp Biol Med 1972; 141: 593-598
45. Merrill GF, Downey F, Jones CE: Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol 1986; 250: H579-H583
46. Wei HM, Kang YH, Merill GF: Coronary vasodilation during global myocardial hypoxia: effect of adenosine deaminase. Am J Physiol 1988; 254: H1004-H1009
47. Rubio R, Berne RM: Regulation of coronary blood flow. Prog Cardiavasc Dis 1975; 18: 105-122
48. Itoh R: Regulation of cytosol-5′-nucleotidase by adenylate energy charge. Biochim Biophys Acta 1981; 659: 31-37
49. Frick GP, Lowenstein JM: Studies of 5′-nucleotidases in the perfused rat heart, including measurements of the enzyme in perfused skeletal muscle and liver. J Biol Client 1976; 251: 6372-6378
50. Worku Y, Newby AC: The mechanism of adenosine production in rat polymorphonuclear leukocytes. Biochem J 1983; 214: 1-6
51. Pearson JD, Hellewell PG, Gordon JL: Adenosine uptake and adenine nucleotide metabolism by vascular endothelium. In: Berne RM, Rall TW, Rubio R, editors. Regulatory function of adenosine. Boston: Martinus Nijhoff, 1983: 333-346
52. Pearson JD, Carleton JS, Gordon J: Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 1980; 190: 421-429
53. 1-Adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ Res 1987; 60: 631-639
54. Hori M, Tamai J, Kitakaze M, Iwakura K, Gotoh K, Iwai K, et al: Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol 1989; 257: H244-H251
55. Buxton ILO, Walther J, Westfall DP: Purinergic mechanisms in cardiac blood vessels: stimulation of endothelial cell alpha receptors in vitro by the neurotransmitter norepinephrine leads to the rapid release of ATP and its subsequent breakdown to adenosine (abstract). Heart Vessel 1990; 4 (Suppl): 27
56. 1-Adrenoceptor activation increases ectosolic 5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 1995; 91: 2226-2234
57. Kitakaze M, Minamino T, Node K, Komamura K, Inoue M, Hori M, Kamada T: Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 1996; 28: 1945-1955
58. Hermann SC, Feigl EO: Adrenergic blockade blunts adenosine concentration and coronary vasodilation during hypoxia. Circ Res 1992; 70: 1203-1216
59. DeWitt DF, Wangler RD, Thompson CI, Sparks Jr HV: Phasic release of adenosine during steady state metabolic stimulation in the isolated guinea pig heart. Circ Res 1983; 53: 636-643
60. Hori M, Kitakaze M, Tamai J, Iwakura K, Kitabatake A, Inoue M, Kamada T: Alpha2-adrenoceptor stimulation can augment coronary vasodilation maximally induced by adenosine in dogs. Am J Physiol 1989; 257: H132-H140
61. 2-Adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol 1988; 255: H250-H260
62. 2-activity on ischemic myocardium during coronary hypoperfusion in dogs. Circ Res 1989; 65: 1632-1645
63. Nayler WG, Price JM, Lowe TE: Inhibition of adenosine-induced coronary vasodilation. Cardiovasc Res 1967; 1: 63-66
64. Berne RM, Rubio R, Curnish RR: Release of adenosine from ischemic brain: effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res 1974; 35: 262-271
65. Agarwal KC: Adenosine and platelet function. In: Stefanovich V, Okayuz-Baklouti I, editors. Role of adenosine in cerebral metabolism and blood flow. Utrecht, The Netherlands: VNU Science Press, 1987: 107-124
66. Newman WH, Becker BF, Heier M, Nees S, Gerlach E: Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts. Pflugers Arch 1988; 413: 1-7
67. Kitakaze M, Hori M, Sato H, Takashima S, Inoue M, Kitabatake A, Kamada T: Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 1991; 69: 1402-1408
68. Minamino T, Kitakaze M, Asanuma H, Tomiyama Y, Shiraga M, Sato H, et al: Endogenous adenosine inhibits P-selectin-dependent formation of coronary thrombi during hypoperfusion in dogs. J Clin Invest 1998; 101: 1643-1653
69. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R: Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986; 78: 760-770
70. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R: Adenosine: a physiological modulator of Superoxide anion generation by human neutrophils. J Exp Med 1986; 158: 1160-1177
71. Cronstein BN: Adenosine is an autacoid of inflammation: effects of adenosine on neutrophil function. In: Imai S, Nakazawa M, editors. Role of adenosine and adenine nucleotides in the biological system. Amsterdam: Elsevier Science Publisher, 1991: 515-520
72. Kitakaze M, Hori M, Morioka T, Takashima S, Sato H, Minamino T, et al: Attenuation of 5′-nucleotides and adenosine release in activated human polymorphonuclear leukocytes. Circ Res 1993; 73: 524-533
73. Belardinelli L, Isenberg G: Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 1983; 53: 287-297
74. Sato H, Hori M, Kitakaze M, Takashima S, Inoue M, Kitabatake A, Kamada T: Endogenous adenosine attenuates beta-adrenoceptor-mediated inotropic response in the hypoperfused canine myocardium. Circulation 1992; 85: 1594-1603
75. Richardt G, Wassa W, Kranzhofer R, Mayer E, Schoming A: Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ 1987; 61: 117-123
76. Rona G: Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985; 17: 291-306
77. Kitakaze M, Takashima S, Sato H: Stimulation of adenosine A1 and A2 receptors prevents myocardial stunning (abstract). Circulation 1990; 82: III-37
78. 1-adrenoceptor activity on myocardial stunning in dogs. Circ Res 1991; 68: 1322-1339
79. Isenberg G, Belardinelli L: Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 1984; 55: 309-325
80. Isenberg G, Cerbai E, Klockner U: Ionic channels and adenosine in isolated heart cells. In: Gerlach E, Becker BF, editors. Topics and perspective in cardiovascular research. Berlin: Springer-Verlag, 1987: 323-335
81. Kitakaze M, Weisman HF, Marban E: Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 1988; 77: 685-695
82. 2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance methods as applied for the study of ischemia and reperfusion. Circ Res 1990; 66: 1255-1267
83. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, et al: Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 1986; 250: H509-H518
84. Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, et al: Role of oxygen-mediated free radicals in myocardial edema and ischemia in coronary microembolization. Circulation 1991; 84: 828-840
85. Kitakaze M, Hori M, Takashima S, Iwai K, Sato H, Inoue M, et al: Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs: a role of 5′-nucleotidase activity. Circ Res 1992; 71: 558-566
86. Kitakaze M, Hori M, Takasima S, Morioka T, Minamino T, Inoue M, Kamada T: Superoxide dismutase protects the degradation of myocardial ectosolic 5′-nucleotidase and increases adenosine release during ischemia and reperfusion. Biorheology 1993; 30: 359-371
87. Olafsson B, Forman MB, Puett DW, Pou A, Gates CU, Friesinger GC, Virmani R: Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987; 76: 1135-1145
88. Takeo S, Tanonaka K, Miyake K, Imago M: Adenine nucleotide metabolites are beneficial for recovery of cardiac contractile force after hypoxia. J Mol Cell Cardiol 1988; 20: 187-199
89. Engler R: Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia. Fed Proc 1987; 46: 2407-2412
90. Foker JE, Einzig E, Wang T: Adenosine metabolism and myocardial preservation. J Thorac Cardiovasc Surg 1980; 80: 506-516
91. Reibel DK, Rovette MJ: Myocardial adenosine salvage rates and restoration of ATP content following ischemia. Am J Physiol 1979; 237: H247-H252
92. Isselhard W, Eitenmuller J, Maurer W, DeVreese A, Reinke H, Czerniak A, et al: Increase in myocardial adenine nucleotides induced by adenosine: dosage, mode of application and duration, species differences. J Moll Cell Cardiol 1980; 12: 619-634
93. Belle van H: Uptake and deamination of adenosine by blood: species differences, effect of pH, ions, temperature, and metabolic inhibition. Biochim Biophys Acta 1969; 192: 124-132
94. Mauser M, Hoffmeister HM, Nienber C, Schaper W: Influence of ribose, adenosine, and 'AICAR' on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog. Circ Res 1985; 56: 220-230
95. Dole VP: Insulin-like actions of ribonucleic acid, adenylic acid, and adenosine. J Biochem Chem 1962; 237: 2758-2762
96. Green A, Newsholme EA: Sensitivity of glucose uptake and lipolysis of white adipoytes of the rat to insulin and effects of some metabolites. Biochem J 1979; 180: 365-370
97. Schwabe U, Schonhofer PS, Ebert R: Facilitaion by adenosine of the action of insulin on the accumulation of adenosine 3′,5′-monophosphate, lipolysis, and glucose oxidation in isolated fat cells. Eur J Biochem 1974; 46: 536-545
98. Raberger G, Kraupp O, Stuhlinger W, Nell G, Chirikdjiam JJ: The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and myocardial metabolism in dogs. Pflugers Arch 1970; 317: 20-34
99. Mainwaring RD, Mentzer Jr RM: Effects of dipyridamole on myocardial glucose uptake in the newborn lamb. J Surg Res 1986; 40: 528-533
100. Jenning RB, Haukins HK, Lowe JE, Hill KL, Klotman S, Reimer KA: Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol 1978; 92: 187-214
101. Taegtmeyer H, Roberts AFC, Raine AEG: Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J Am Coll Cardiol 1985; 6: 864-870
102. Ambrosio G, Jacobus WE, Decker LC: Effect of ATP precursor administration on post-ischemic function and metabolism in isolated rabbits hearts (abstract). J Am Coll Cardiol 1986; 7: 79A
103. Nunnally RL, Hollis DP: Adenosine triphosphate compartmentation in living hearts: a phosphorus nuclear magnetic resonance saturation transfer study. Biochemistry 1979; 18: 3642-3646
104. 31P-NMR magnetization transfer study. J Biol Chem 1985; 260: 3512-3517
105. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O: Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 1992; 86: 979-985
106. Zahler S, Becker BF, Raschke P, Gerlach E: Stimulation of endothelial adenosine A1 receptors enhances adhesion of neutrophils in intact guinea pig coronary system. Cardiovasc Res 1994; 28: 1366-1372
107. Zhao J, Renner O, Latchman DS, Marber M: The role of adenosine in the mediation of the resistance to simulated ischemia that follows expression of constitutively active PDC-β. Circulation 1997; 96:1-450
108. Zhao J, Heads RJ, Wightman L, Marber M: PKC-mediated cardioprotection requires adenosine receptor reoccupation. Circulation 1998; 98: 1-71
109. Van Wylen DGL: Effects of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89: 2283-2289
110. Przyklenk K, Hata K, Zhas L, Kloner RA, Elliott GT: Disparate effects of preconditioning and MLA on 5′-NT and adenosine levels during coronary occlusion. Am J Physiol 1997; 273: H945-H951
111. Al-Awqati Q: Regulation of ion channels by ABC transporters that secrete ATP. Science 1995; 269: 805-806
112. Kitakaze M, Funaya H, Minamino T, Node K, Sato H, Ueda Y, et al: Role of Protein Kinase C-α in activation of ecto-5′-nucleotidase in the preconditioned canine myocardium. Biochem Biophys Res Commun 1997; 239: 171-175
113. Savic V, Stefanovic V, Ardaillou N, Ardaillou R: Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1β and tumor necrosis factor-α. Immunology 1990; 70: 321-326
114. Mashaffey K, Puma JA, Barbagelata A, Casas CA, Lambe L, Orlandi C, et al: Does adenosine in conjugation with thrombosis reduce infarct size? Results from the controlled, randomized AMISTAD Trial. Circulation 1997; 96: I-206-I-207